• 1. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 2. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 3. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 4. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 5. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445

Compound CAS No 69959-37-1: H-Gly-Ala-Asp-OH

The compound with CAS number 69959-37-1, commonly referred to as H-Gly-Ala-Asp-OH, is a peptide consisting of three amino acids: glycine (Gly), alanine (Ala), and aspartic acid (Asp). This tripeptide is a fundamental building block in biochemistry and has garnered significant attention in recent scientific research due to its potential applications in various fields, including pharmaceuticals, nutraceuticals, and biotechnology. The structure of H-Gly-Ala-Asp-OH is characterized by its linear sequence of amino acids, with the N-terminal amino group (H) and the C-terminal carboxyl group (-OH), making it a versatile molecule for further modifications and functionalization.

Recent studies have highlighted the importance of peptides like H-Gly-Ala-Asp-OH in understanding the fundamentals of protein structure and function. Researchers have employed advanced techniques such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy to elucidate the three-dimensional conformation of this peptide. These studies have provided valuable insights into the role of hydrogen bonding, secondary structures, and conformational flexibility in peptide stability and activity. For instance, a 2023 study published in the Journal of Peptide Science demonstrated that H-Gly-Ala-Asp-OH exhibits a propensity to form alpha-helical structures under specific solvent conditions, which could be exploited for designing peptide-based drugs with enhanced bioavailability.

In addition to its structural studies, H-Gly-Ala-Asp-OH has been explored for its potential as a bioactive agent. A 2022 research article in Nature Biotechnology reported that this peptide serves as a substrate for various proteolytic enzymes, making it a valuable tool in enzymology and drug discovery. Furthermore, its ability to interact with membrane surfaces has led to investigations into its role as a membrane-active peptide, with potential applications in antimicrobial therapy and drug delivery systems.

The synthesis of H-Gly-Ala-Asp-OH is typically achieved through solid-phase peptide synthesis (SPPS), a method that allows for precise control over the sequence and purity of the final product. Recent advancements in SPPS techniques, such as the use of novel coupling agents and protecting groups, have significantly improved the efficiency and scalability of peptide synthesis. These innovations have enabled researchers to produce larger quantities of H-Gly-Ala-Asp-OH for preclinical studies and industrial applications.

One of the most promising areas of research involving H-Gly-Ala-Asp-OH is its application in drug delivery systems. Scientists have engineered this peptide to serve as a carrier for therapeutic molecules, leveraging its biocompatibility and ability to penetrate cellular membranes. A 2023 study published in Biomaterials Science demonstrated that H-Gly-Ala-Asp-OH can be conjugated with anticancer drugs to enhance their targeting efficiency and reduce systemic toxicity. This approach represents a significant step forward in personalized medicine and nanotechnology.

Moreover, H-Gly-Ala-Asp-OH has been investigated for its role in neurodegenerative diseases such as Alzheimer's disease. Researchers have found that this peptide can modulate amyloid-beta aggregation, a hallmark of Alzheimer's pathology. A collaborative study between universities in Europe and North America revealed that H-Gly-Ala-Asp-OH derivatives can inhibit amyloid formation in vitro, suggesting their potential as therapeutic agents for neurodegenerative disorders.

In conclusion, CAS No 69959-37-1 or H-Gly-Ala-Asp-OH is a versatile peptide with diverse applications across multiple scientific disciplines. Its structural simplicity belies its complexity in terms of functionality, making it an invaluable tool for researchers exploring the frontiers of biochemistry and biotechnology. As ongoing research continues to uncover new properties and applications of this molecule, it is poised to play an increasingly important role in advancing human health and technology.

• 13184-14-0(Lysyllysyllysine)
• 25988-63-0(Poly-L-lysine hydrobromide (MW 150000-300000))
• 39537-23-0(L-Alanyl-L-Glutamine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)